ISHRS 2023 CME Webinar

Let’s Talk About the Future in Medical Treatments for Hair Loss

Presented on
Wednesday, April 26, 2023
9AM to 11AM Central Time/Chicago
(Time Zone Conversion)
Duration: 2 hours

Available On Demand – Register below to view the recording

Registration Fees Per Webinar

Physician Attendee of ISHRS 2022 Panama World Congress	$0.00 USD
ISHRS Physician Member Non-Attendee of ISHRS 2022 Panama World Congress	$75.00 USD
ISHRS Physician Pending-Member Non-Attendee of ISHRS 2022 Panama World Congress	$100.00 USD
Physician Non-Member Non-Attendee of ISHRS 2022 Panama World Congress	$125.00 USD

PROGRAM OUTLINE (PDF)

Moderators

Moderator: Marie Schambach, MD, FISHRS | Guatemala
Co-Moderator: Oscar Muñoz Moreno-Arrones, MD, PhD | Spain

Program Description

The live online webinar will occur on the date and time as noted. The live program will be recorded and available for viewing on demand until January 10, 2024. This 2-hour CME activity is a live webinar which will be recorded with the intention to be re-watched or viewed as on-demand education. This webinar is being conducted to provide physicians with scientific updates and current studies related to medical management for patients with different types of hair loss. As a result of this activity, learners will be able to gain more knowledge in current practices to manage the wide range of hair-loss conditions.

The online live component will include presentations, panel discussion, and audience participation via verbal questions and discussion, typing chat Q&A and polling.

Professional Practice Gap

Hair loss is still a complicated condition to treat. Actual medical management can be difficult and can carry many types of side effects. New developments in medical treatments should be assessed, learned, and included if applicable in our daily practices. The goal is to bring all hair doctors up to speed with current studies, with a diverse number of disease treatments and methodologies to improve patients’ outcomes.

Educational Need

Most webinars cover routine therapies for hair loss for the practicing hair doctor. These subjects are partially addressed in many textbooks and scientific articles. However, the audience for this webinar will be the intermediate and more advanced practitioner who would benefit greatly from the subjects covered in this webinar, representing current advancements which can be applied in our own clinical practice. Hopefully, not only will methodology be outlined but also a vibrant debate and discussion will ensue to help foster greater dialogue and refinement of those ideas.

Learning Objectives

As a result of participating in this webinar, the attendees should be able to:

Discuss up-to-date male and female pattern hair loss treatment
Explain upcoming treatments for androgenetic alopecia
Describe the use of JAKi in alopecia areata and other lymphocytic alopecia
Give examples of how to improve hair density in non-androgenetic alopecia

Target Audience and Prerequisites

This webinar is taught at the physician level. It is open to all levels and geared toward advanced hair restoration surgeons.

References

Vañó-Galván, S., & Camacho, F. (2017). New treatments for hair loss. Actas Dermo-Sifiliográficas (English Edition), 108(3), 221-228.
Feldman, P. R., Gentile, P., Piwko, C., Motswaledi, H. M., Gorun, S., Pesachov, J., … & Fiebig, K. M. (2023). Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. Frontiers in Medicine, 9, 3800.
Castro, A. R., Portinha, C., & Logarinho, E. (2023). The booming business of hair loss. Trends in Biotechnology.
Natarelli, N., Gahoonia, N., & Sivamani, R. K. (2023). Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss. Journal of Clinical Medicine, 12(3), 893.
Sedeh, F. B., Michaelsdóttir, T. E., Henning, M. A. S., Jemec, G. B. E., & Ibler, K. S. (2023). Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis. Acta Dermato-Venereologica, 103.
Vyas, K. S., Kaufman, J., Munavalli, G. S., Robertson, K., Behfar, A., & Wyles, S. P. (2023). Exosomes: the latest in regenerative aesthetics. Regenerative Medicine, 18(2), 181-194.

CME Information

Continuing Medical Education (CME) Credit Statement

The International Society of Hair Restoration Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The International Society of Hair Restoration Surgery designates this Other Activity (blended synchronous and enduring) for a maximum of 2.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To receive CME credit and a CME certificate, participants must participate in the activity, complete the evaluation survey and the CME Claim Form by January 10, 2024.

Format

Internet/online, via computer or mobile device.

Official Language

The official language of the webinar is English. Simultaneous interpretation is not provided for this webinar.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the ISHRS must ensure that anyone in a position to control the content of the educational activity (planners/ speakers/authors/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ISHRS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Disclosures of Relevant Financial Relationships of Planners, Faculty, and Others

The following individuals have no relevant financial relationships with ineligible companies to disclose:

Planners

Conradin von Albertini, MD, FISHRS – Planner
Waris Anwar, MBBS, FISHRS – Planner
Victoria Ceh, MPA – Planner & Manager
Bruno F. Ferreira, MD – Planner
Steven Gabel, MD, FISHRS – Planner
James A. Harris, MD, FISHRS – Planner
Rana Irfan, MBBS, FISHRS – Planner
Emily Middag – Planner and Manager
Ratchathorn Panchaprateep, MD, PhD, FISHRS – Planner
Mauro Speranzini, MD, FISHRS – Faculty
Melanie Stancampiano – Planner & Manager
Mark A. Waldman, MD – Planner

Faculty

The following individuals have relevant financial relationships:

Planners

None

Faculty

Rodrigo Pirmez, MD | Brazil – Faculty: GlaxoSmithKline Brasil: Speaker [dutasteride]

All of the relevant financial relationships listed for these individuals have been mitigated.

Commercial Support

None.

Off-Label Or Other Non-FDA Approved, Investigational Use

Rubina Alves, MD – Cell Therapy
Hairclone; Replicel (RCH01); Epibiotech (Epi-001); TissUse (SHT); Platelet rich plasma; Rigenera; Adipose derived stem cell; Exosomes (Not On-label for the treatment of any disorder at the present time).

Bevin Bhoyrul, MD – Bicalutamide: Oral and Mesotherapy
Bicalutamide; low-dose oral minoxidil; spironolactone

Oscar Muñoz Moreno-Arrones, MD, PhD – New Treatments for Androgenetic Alopecia
Dutasteride; oral minoxidil

Daniel Ortega, MD – Oral Minoxidil for Non-Androgenetic Alopecias
Oral minoxidil

Rodrigo Pirmez, MD – Oral Dutasteride and Oral Minoxidil: The Off-label Gold Standard for Male Androgenetic Alopecia?
Dutasteride; oral minoxidil

Ronald L. Shapiro, MD, FISHRS – Exosomes: What Do We Know? Will They Work?
Exosomes; Not On-label for the treatment of any disorder at the present time.

Other CME Information

Click for Continuing Medical Education Mission Statement
Learner Bill of Rights
ISHRS Privacy and Confidentiality Policy for Internet CME

Disclaimer

The webinar content has been made available by the ISHRS for educational purposes only. The content is not intended to represent the only, nor necessarily the best, method or procedure appropriate for the medical situations discussed, but rather is intended to present views, statements, and opinions that may be of interest to others. The views expressed herein are those of the individual authors and not necessarily those of the ISHRS. The ISHRS assumes no responsibility or liability in connection with your use or misuse of the webinar content or any materials or techniques described in the content, and it makes no warranty or representation as to the validity or sufficiency of any information provided.

Questions: Learners may contact the ISHRS Headquarters with questions about this CME activity at phone +1-800-444-2737 or +1-630-262-5399, or fax +1-630-262-1520, or email: [email protected]

ISHRS 2023 CME Webinar April 26 – Let’s Talk About the Future in Medical Treatments for Hair Loss